John Yarnold

19.7k citations

194 papers · 10.5k · 4 hit papers · h-index 50

Impact in

Cancer Research top 0.1%
- Breast Cancer Treatment Studies
Radiation top 0.1%
- Advanced Radiotherapy Techniques

Papers in

Cancer Research 96
- Breast Cancer Treatment Studies 90
Oncology 54
- Global Cancer Incidence and Screening 14
- Lung Cancer Research Studies 9

Co-authors: Joanne Haviland (41 shared papers)Judith M. Bliss (35 shared papers)Philip Evans (22 shared papers)Ellen M. Donovan (21 shared papers)John R. Owen (9 shared papers)Søren M. Bentzen (7 shared papers)Peter Hoskin (11 shared papers)Anna M. Kirby (24 shared papers)
Journals: Radiotherapy and Oncology (71 papers)Clinical Oncology (21 papers)International Journal of Radiation Oncology*Biology*Physics (10 papers)British Journal of Radiology (10 papers)The Lancet Oncology (7 papers)
Partner nations: United Kingdom United States Germany

In The Last Decade

John Yarnold

188 papers receiving 10.2k citations

John Yarnold's Hit Papers

align trajectories log scale

ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer 2015 · 497 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2015 Radiotherapy and Oncology
2013 The Lancet Oncology
2010 Radiotherapy and Oncology
1999 The Lancet

Peers

Countries citing papers authored by John Yarnold

Since Specialization

Citations

This map shows the geographic impact of John Yarnold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Yarnold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Yarnold more than expected).

Fields of papers citing papers by John Yarnold

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Yarnold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Yarnold. The network helps show where John Yarnold may publish in the future.

Co-authors

The 25 scholars most cited alongside John Yarnold, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John Yarnold Line = papers co-authored together John Yarnold links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 194 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials The Lancet Oncology ·Joanne Haviland, John R. Owen, John Dewar, R. K. Agrawal, Jane Barrett, Peter Barrett‐Lee, H.J. Dobbs, Penelope Hopwood, P.A. Lawton, Brian Magee, Judith Mills, Sandra F. Simmons, Mark Sydenham, Karen Venables, Judith M. Bliss, John Yarnold Hit paper breakdown →	2013	965
2	Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial The Lancet ·David P. Dearnaley, Vincent Khoo, A. Norman, Lesley Meyer, Alan E. Nahum, Diana Tait, John Yarnold, Alan Horwich Hit paper breakdown →	1999	540
3	ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer Radiotherapy and Oncology ·Birgitte Vrou Offersen, Liesbeth Boersma, Carine Kirkove, S. Hol, Marianne Aznar, Albert Biete Solá, Youlia Kirova, Jean‐Philippe Pignol, Vincent Remouchamps, Karolien Verhoeven, Caroline Weltens, Meritxell Arenas, Dorota Gabryś, Neil Kopek, Mechthild Krause, Dan Lundstedt, Tanja Marinko, Á. Montero, John Yarnold, Philip Poortmans Hit paper breakdown →	2015	497
4	Pathogenetic mechanisms in radiation fibrosis Radiotherapy and Oncology ·John Yarnold, (unknown) Hit paper breakdown →	2010	487
5	Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial The Lancet Oncology ·John R. Owen, (unknown), Judith M. Bliss, Janis Homewood, C Harper, Jane Hanson, Joanne Haviland, Søren M. Bentzen, John Yarnold	2006	426
6	Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomised trial Radiotherapy and Oncology ·John Yarnold, (unknown), Judith M. Bliss, Janis Homewood, C Harper, Jane Hanson, Joanne Haviland, Søren M. Bentzen, Roger Owen	2005	375
7	Randomised trial of standard 2D radiotherapy (RT) versus intensity modulated radiotherapy (IMRT) in patients prescribed breast radiotherapy Radiotherapy and Oncology ·Ellen M. Donovan, Natalie Bleakley, Erica Denholm, Philip Evans, Lone Gothard, Jane Hanson, Clare Peckitt, Stephanie Reise, Gill Ross, Grace Sharp, Richard Symonds‐Tayler, Diana Tait, John Yarnold	2007	354
8	Prospective randomised trial of single and multifraction radiotherapy schedules in the treatment of painful bony metastases Radiotherapy and Oncology ·P. Price, Peter Hoskin, Douglas F. Easton, D. Austin, S. Palmer, John Yarnold	1986	343
9	aTTom: Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years in 6,953 women with early breast cancer. Journal of Clinical Oncology ·Richard Gray, Daniel Rea, Kelly Handley, S. Bowden, Philip Perry, Helena Earl, Christopher Poole, T Bates, Shan Chetiyawardana, John Dewar, Indrajit Fernando, Robert Grieve, J. J. Nicoll, Zenor Rayter, A. Robinson, Asad Salman, John Yarnold, Sarah Bathers, Andrea Marshall, Martin Lee, (unknown)	2013	291
10	Prophylactic cranial irradiation is indicated following complete response to induction therapy in small cell lung cancer: Results of a multicentre randomised trial European Journal of Cancer ·A. Gregor, A. Cull, Richard Stephens, John A. Kirkpatrick, John Yarnold, D.J. Girling, Fergus Macbeth, R. Stout, David Machin	1997	260
11	The influence of breast size on late radiation effects and association with radiotherapy dose inhomogeneity Radiotherapy and Oncology ·A.M. Moody, W. P. M. Mayles, Judith M. Bliss, Roger A’Hern, John R. Owen, J. Regan, B. Broad, John Yarnold	1994	226
12	A prospective randomised trial of 4 Gy or 8 Gy single doses in the treatment of metastatic bone pain Radiotherapy and Oncology ·Peter Hoskin, P. Price, Douglas F. Easton, J. Regan, D. Austin, S. Palmer, John Yarnold	1992	177
13	Comparison of patient-reported breast, arm, and shoulder symptoms and body image after radiotherapy for early breast cancer: 5-year follow-up in the randomised Standardisation of Breast Radiotherapy (START) trials The Lancet Oncology ·Penelope Hopwood, Joanne Haviland, G. Sumo, Judith Mills, Judith M. Bliss, John Yarnold	2010	173
14	The UK HeartSpare Study: Randomised evaluation of voluntary deep-inspiratory breath-hold in women undergoing breast radiotherapy Radiotherapy and Oncology ·Frederick R. Bartlett, R. Colgan, Karen Carr, Ellen M. Donovan, H. McNair, Imogen Locke, Philip Evans, Joanne Haviland, John Yarnold, Anna M. Kirby	2013	158
15	Acute skin toxicity associated with a 1-week schedule of whole breast radiotherapy compared with a standard 3-week regimen delivered in the UK FAST-Forward Trial Radiotherapy and Oncology ·Adrian Murray Brunt, Duncan Wheatley, John Yarnold, Navita Somaiah, Stephen Kelly, Adrian Harnett, Charlotte E. Coles, Andrew Goodman, Amit Bahl, Mark Churn, R. Zotova, Mark Sydenham, Clare Griffin, James P. Morden, Judith M. Bliss	2016	155
16	Cosmetic and functional outcomes of breast conserving treatment for early stage breast cancer. 1. Comparison of patients' ratings, observers' ratings and objective assessments Radiotherapy and Oncology ·K.C.A. Sneeuw, Neil K. Aaronson, John Yarnold, M. Broderick, J. Regan, Gayle Ross, Audrey D. Goddard	1992	147
17	Correlation of breast dose heterogeneity with breast size using 3D CT planning and dose-volume histograms Radiotherapy and Oncology ·Anthony Neal, M. Torr, S.J. Helyer, John Yarnold	1995	127
18	Prone versus supine positioning for whole and partial-breast radiotherapy: A comparison of non-target tissue dosimetry Radiotherapy and Oncology ·Anna M. Kirby, Philip Evans, Ellen M. Donovan, Helen M. Convery, Joanne Haviland, John Yarnold	2010	126
19	Carboplatin: a very active new cisplatin analog in the treatment of small cell lung cancer. PubMed ·Smith Ie, S. J. Harland, Bridget A. Robinson, Evans Bd, Goodhart Lc, Calvert Ah, John Yarnold, Glees Jp, J Baker, Ford Ht	1985	126
20	Hypofractionated Whole-Breast Radiotherapy for Women With Early Breast Cancer: Myths and Realities International Journal of Radiation OncologyBiologyPhysics ·John Yarnold, Søren M. Bentzen, Charlotte E. Coles, Joanne Haviland	2010	107

About John Yarnold

John Yarnold is a scholar working on Cancer Research, Oncology, Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Radiation, having authored 194 papers that have together received 10.5k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (90 papers), Advanced Radiotherapy Techniques (28 papers), Effects of Radiation Exposure (25 papers), Breast Lesions and Carcinomas (17 papers), Advances in Oncology and Radiotherapy (14 papers), Global Cancer Incidence and Screening (14 papers), Management of metastatic bone disease (9 papers) and Lung Cancer Research Studies (9 papers). The work is most often cited by research in Cancer Research (4.2k citations), Radiation (2.0k citations), Radiology, Nuclear Medicine and Imaging (2.2k citations), Oncology (2.2k citations) and Pulmonary and Respiratory Medicine (2.0k citations). John Yarnold has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Joanne Haviland, Judith M. Bliss, Philip Evans, Ellen M. Donovan, John R. Owen, Søren M. Bentzen, Peter Hoskin, Anna M. Kirby, Jane Hanson and J. Regan. Their work appears in journals such as Radiotherapy and Oncology, Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics, British Journal of Radiology and The Lancet Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

John Yarnold

Impact in

Papers in i

In The Last Decade

John Yarnold

John Yarnold's Hit Papers

Peers

Countries citing papers authored by John Yarnold

Fields of papers citing papers by John Yarnold

All Works

About John Yarnold

Explore authors with similar magnitude of impact

Papers in